266 related articles for article (PubMed ID: 21540357)
1. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
2. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
5. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
6. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice.
Duysen EG; Li B; Carlson M; Li YF; Wieseler S; Hinrichs SH; Lockridge O
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):514-21. PubMed ID: 19067679
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of butyrylcholinesterase for cocaine intoxication.
Mattes CE; Lynch TJ; Singh A; Bradley RM; Kellaris PA; Brady RO; Dretchen KL
Toxicol Appl Pharmacol; 1997 Aug; 145(2):372-80. PubMed ID: 9266811
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.
Carmona GN; Jufer RA; Goldberg SR; Gorelick DA; Greig NH; Yu QS; Cone EJ; Schindler CW
Drug Metab Dispos; 2000 Mar; 28(3):367-71. PubMed ID: 10681384
[TBL] [Abstract][Full Text] [Related]
9. Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.
Parikh K; Duysen EG; Snow B; Jensen NS; Manne V; Lockridge O; Chilukuri N
J Pharmacol Exp Ther; 2011 Apr; 337(1):92-101. PubMed ID: 21205915
[TBL] [Abstract][Full Text] [Related]
10. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Chilukuri N; Duysen EG; Parikh K; Sun W; Doctor BP; Lockridge O; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):327-31. PubMed ID: 18499092
[TBL] [Abstract][Full Text] [Related]
12. Cocaine detoxification by human plasma butyrylcholinesterase.
Lynch TJ; Mattes CE; Singh A; Bradley RM; Brady RO; Dretchen KL
Toxicol Appl Pharmacol; 1997 Aug; 145(2):363-71. PubMed ID: 9266810
[TBL] [Abstract][Full Text] [Related]
13. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
14. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
[TBL] [Abstract][Full Text] [Related]
15. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India.
Manoharan I; Boopathy R; Darvesh S; Lockridge O
Clin Chim Acta; 2007 Mar; 378(1-2):128-35. PubMed ID: 17182021
[TBL] [Abstract][Full Text] [Related]
16. The butyrylcholinesterase knockout mouse is obese on a high-fat diet.
Li B; Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):88-91. PubMed ID: 18452903
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase deficiency.
Delacour H; Dedome E; Courcelle S; Hary B; Ceppa F
Ann Biol Clin (Paris); 2016 Jun; 74(3):279-85. PubMed ID: 27237801
[TBL] [Abstract][Full Text] [Related]
19. Visualizing viral transduction of a cocaine-hydrolyzing, human butyrylcholinesterase in rats.
Gao Y; Brimijoin S
Chem Biol Interact; 2005 Dec; 157-158():97-103. PubMed ID: 16243302
[TBL] [Abstract][Full Text] [Related]
20. The influence of plasma butyrylcholinesterase concentration on the in vitro hydrolysis of cocaine in human plasma.
Browne SP; Slaughter EA; Couch RA; Rudnic EM; McLean AM
Biopharm Drug Dispos; 1998 Jul; 19(5):309-14. PubMed ID: 9673783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]